Free tool
FAERS Monitor: Admelog
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming BLA 209196 or its brand name (Admelog, Insulin Lispro). Reports on generic versions are filed under their own applications.
Reports
14,537
Serious
8,838
61% of reports
Hospitalization
5,398
Death reported
990
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- blood glucose increased2,450
- incorrect dose administered887
- drug ineffective835
- hypoglycaemia676
- visual impairment634
- nausea606
- dyspnoea575
- off label use508
- product dose omission issue507
- blood glucose decreased477
- vomiting447
- diarrhoea436
- fatigue424
- acute kidney injury411
- headache391
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 61 |
| 2005 | 60 |
| 2006 | 38 |
| 2007 | 44 |
| 2008 | 65 |
| 2009 | 74 |
| 2010 | 79 |
| 2011 | 74 |
| 2012 | 109 |
| 2013 | 131 |
| 2014 | 194 |
| 2015 | 279 |
| 2016 | 292 |
| 2017 | 325 |
| 2018 | 707 |
| 2019 | 926 |
| 2020 | 1,415 |
| 2021 | 1,460 |
| 2022 | 1,568 |
| 2023 | 1,638 |
| 2024 | 1,648 |
| 2025 | 1,955 |
| 2026 | 1,395 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,039,622 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| hypoglycaemiaSignal | 676 | 20.4 | 19.0 | 12,331 |
| blood glucose increasedSignal | 2,450 | 19.0 | 18.4 | 41,710 |
| blood glucose decreasedSignal | 477 | 14.5 | 13.3 | 5,939 |
| visual impairmentSignal | 634 | 7.4 | 6.9 | 3,528 |
| incorrect dose administeredSignal | 887 | 5.6 | 5.3 | 3,405 |
| acute kidney injurySignal | 411 | 3.9 | 3.5 | 885 |
| product dose omission issueSignal | 507 | 2.5 | 2.3 | 459 |
| dyspnoea | 575 | 1.5 | 1.4 | 88 |
| vomiting | 447 | 1.4 | 1.3 | 47 |
| nausea | 606 | 1.1 | 1.0 | 7 |
| diarrhoea | 436 | 1.0 | 0.9 | 0 |
| drug ineffective | 835 | 0.9 | 0.9 | 7 |
| headache | 391 | 0.9 | 0.8 | 4 |
| off label use | 508 | 0.8 | 0.8 | 16 |
| fatigue | 424 | 0.8 | 0.7 | 25 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.